Company Filing History:
2 out of 2,310 
2 out of 1,271 
2 out of 84 
Years Active: 2021-2025
Title: Robert Zeiser: Innovating Therapeutic Methods in Graft-Versus-Host Disease
Introduction
Robert Zeiser, an influential inventor based in Freiburg, Germany, has made significant contributions in the field of biomedical innovations. With a focus on therapeutic methods involving the modulation of inflammasome activation of myeloid-derived suppressor cells, he has been awarded two important patents that further the understanding and treatment of complex medical conditions.
Latest Patents
One of Zeiser's notable patents explores therapeutic methods for treating subjects experiencing or at risk of graft-versus-host disease (GvHD). The method includes administering a plurality of myeloid-derived suppressor cells (MDSCs) to patients, aiming to alleviate symptoms or clinical signs of GvHD effectively. Moreover, his other patent outlines a dual approach to tumor treatment, which involves the co-administration of an anti-tumor therapy and an inflammasome inciting agent. This method is designed to enhance inflammasome activation of MDSCs sufficiently to mitigate their suppressor function, offering a novel avenue in cancer treatment.
Career Highlights
Robert Zeiser's career has been shaped by his work at prestigious institutions such as the University of Minnesota and the University of North Carolina at Chapel Hill. His involvement in academic research has allowed him to contribute towards breakthroughs in medical treatments, particularly in immunology and cancer therapies.
Collaborations
Throughout his career, Zeiser has collaborated with various experts in the field, notably Bruce Robert Blazar and Brent Koehn. These partnerships have fostered a rich exchange of ideas, leading to the successful development of his patented methods and strengthening the impact of his research.
Conclusion
Robert Zeiser exemplifies the spirit of innovation in medical science. His patents on therapeutic methods for treating GvHD and tumors represent a significant advancement in understanding how to manipulate cellular functions for enhanced patient outcomes. With a commendable background in research and collaborations, Zeiser continues to pave the way for future discoveries in treatment modalities.